Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Glioma 3Oligodendroglioma 2Gliosarcoma 2Glioma, Subependymal 2Glioblastoma 2Ependymoma 2Astrocytoma 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Recurrence 1Pinealoma 1Pancreatic Neoplasms 1Pancreatic Intraductal Neoplasms 1Neuroectodermal Tumors, Primitive 1Meningioma 1Medulloblastoma 1Healthy, no Evidence of Disease 1Diffuse Intrinsic Pontine Glioma 1Craniopharyngioma 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Endometrioid 1

Interventions

durvalumab 2tremelimumab 1rocakinogene sifuplasmid 1adavosertib 1VGX-3100 1Radiotherapy 1Radiation 1Platinum 1Palliative Care 1MEDI0457 1Immunoglobulin G 1Disulfides 1Device Removal 1Congresses as Topic 1Cisplatin 1Axitinib 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Vaginal Neoplasms × Congresses as Topic × Clear all
NCT03345784 2024-02-20

Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers

National Cancer Institute (NCI)

Phase 1 Terminated
10 enrolled 15 charts
Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡